0.02
+0.0193(+0.00%)
Currency In USD
Address
12 Gill Street
Woburn, MA 01801
United States of America
Phone
617 871 2101
Sector
Healthcare
Industry
Biotechnology
Employees
12
First IPO Date
December 21, 2020
| Name | Title | Pay | Year Born |
| Mr. Michael G. Campbell CPA | Chief Executive Officer, Chief Financial Officer & Principal Accounting Officer | 269,109 | 1969 |
| Dr. David Soane Ph.D. | Co-Founder & Member of Scientific Advisory Board | 0 | N/A |
| Ms. Janice Marie McCourt B.S., CLP, M.B.A., R.Ph. | Chief Business Officer | 0 | 1962 |
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn's and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.